Company Badge
USPTO Data Jan 1 1976 - Nov 10 2026
5 Patents
#768 in San Francisco, CA
#12,100 in California
#51,743 in US
Via Pharmaceuticals, Inc.
Forward Citations = 66
26 inventors:
San Francisco, CA, United States of America
Via Pharmaceuticals, Inc.
Calculating rank
% Expired Patents = 100.0
Forward Citations = 66
Loading Chart...
Loading Chart...
26 inventors (with patents filed for the assignee):
Yimin Qian (2 out of 73 patents)
Weiya Yun (2 out of 20 patents)
Adrian Wai-Hing Cheung (2 out of 15 patents)
4. Fariborz Firooznia (2 out of 31 patents)
5. David Robert Bolin (2 out of 22 patents)
6. Lee Apostle McDermott (2 out of 9 patents)
7. Matthew Michael Hamilton (2 out of 59 patents)
8. Raymond Tabibiazar (1 out of 6 patents)
9. Jenny Tan (1 out of 9 patents)
10. Thomas Quertermous (1 out of 3 patents)
11. Cesare Mondadori (1 out of 7 patents)
12. Shiming Li (1 out of 1 patent)
13. Melisa Cooper (1 out of 1 patent)
14. Mustapha Abarghaz (1 out of 1 patent)
15. Stefano Biondi (1 out of 6 patents)
5 patents:
Company Overview
Via Pharmaceuticals, Inc. is a biotechnology company focused on developing novel therapies for cardiovascular and metabolic diseases. Their innovative approach integrates cutting-edge research in drug discovery with a deep understanding of disease mechanisms to create targeted treatments that improve patient outcomes. With a commitment to scientific excellence and a passion for improving patient care, Via Pharmaceuticals is dedicated to bringing new, effective therapies to market.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Via Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/via-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]